1. Sawynok J. Purines in pain management. Curr Opin CPNS Invest Drugs. 1999. 1:27–38.
2. Rane K, Segerdahl M, Goiny M, Sollevi A. Intrathecal adenosine administration: a phase 1 clinical safety study in healthy volunteers, with additional evaluation of its influence on sensory thresholds and experimental pain. Anesthesiology. 1998. 89:1108–1115.
3. Weisbuerger JH. Tea and health: the underlying mechanisms. Proc Soc Exp Biol Med. 1999. 220:271–275.
Article
4. Miura S, Watanabe J, Tamita T, Sano M, Tomita I. The inhibitory effects of tea polyphenols (flavan-3-ol derivatives) on Cu
2+ mediated oxidative modification of low density lipoprotein. Biol Pharm Bull. 1994. 17:1567–1572.
Article
5. Singal A, Anjaneyulu M, Chopra K. Modulatory role of green tea extract on antinociceptive effect of morphine in diabetic mice. J Med Food. 2005. 8:386–391.
Article
6. Kaur S, Anurag A, Tirkey N, Chopra K. Reversal of LPS-induced central and peripheral hyperalgesia by green tea extract. Phytother Res. 2005. 19:39–43.
Article
7. Ahmed S, Rahman A, Hasnain A, Lalonde M, Goldberg VM, Haqqi TM. Green tea polyphenol epigallocatechin-3-gallate inhibits the IL-1betainduced activity and expression of cyclooxygenase-2 and nitric oxide synthase-2 in human chondrocytes. Free Radic Biol Med. 2002. 33:1097–1105.
Article
8. Yoon MH, Yaksh TL. The effect of intrathecal gabapentin on pain behavior and hemodynamics on the formalin test in the rat. Anesth Analg. 1999. 89:434–439.
Article
9. Yaksh TL, Rudy TA. Chronic catheterization of the spinal subarachnoid space. Physiol Behav. 1976. 17:1031–1036.
Article
10. Malmberg AB, Yaksh TL. Cyclooxygenase inhibition and the spinal release of prostaglandin E2 and amino acids evoked by paw formalin injection: a microdialysis study in unanesthetized rats. J Neurosci. 1995. 15:2768–2776.
Article
11. Singh R, Ahmed S, Islam N, Goldberg VM, Haqqi TM. Epigallocatechin-3-gallate inhibits interleukin-1beta-induced expression of nitric oxide synthase and production of nitric oxide in human chondrocytes: suppression of nuclear factor kappaB activation by degradation of the inhibitor of nuclear factor kappaB. Arthritis Rheum. 2002. 46:2079–2086.
Article
12. Paquay JB, Haenen GR, Stender G, Wiseman SA, Tijburg LB, Bast A. Protection against nitric oxide toxicity by tea. J Agric Food Chem. 2000. 48:5768–5772.
Article
13. Meller ST, Gebhart GF. Nitric oxide (NO) and nociceptive processing in the spinal cord. Pain. 1993. 52:127–136.
Article
14. Lin JK, Liang YC, Lin-Shiau SY. Cancer chemoprevention by tea polyphenols through mitotic signal transduction blockade. Biochem Pharmacol. 1999. 58:911–915.
Article
15. Grover VS, Sharma A, Singh M. Role of nitric oxide in diabetesinduced attenuation of antinociceptive effect of morphine in mice. Eur J Pharmacol. 2000. 399:161–164.
Article
16. Ahmed S, Rahman A, Hasnain A, Lalonde M, Goldberg VM, Haqqi TM. Green tea polyphenol epigallocatechin-3-gallate inhibits the IL-1beta-induced activity and expression of cyclooxygenase-2 and nitric oxide synthase-2 in human chondrocytes. Free Radic Biol Med. 2002. 33:1097–1105.
Article